203 related articles for article (PubMed ID: 9124843)
1. Postantibiotic and post-beta-lactamase inhibitor effects of amoxicillin plus clavulanate.
Thorburn CE; Molesworth SJ; Sutherland R; Rittenhouse S
Antimicrob Agents Chemother; 1996 Dec; 40(12):2796-801. PubMed ID: 9124843
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
Pottumarthy S; Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
[TBL] [Abstract][Full Text] [Related]
3. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae.
Cooper CE; Slocombe B; White AR
J Antimicrob Chemother; 1990 Sep; 26(3):371-80. PubMed ID: 2121699
[TBL] [Abstract][Full Text] [Related]
4. [In vitro demonstration of a true post-beta-lactamases inhibitor effect (PLIE) of clavulanic acid on Klebsiella pneumoniae and Haemophilus influenzae].
Murbach V; Dhoyen N; Linger L; Monteil H; Jehl F
Pathol Biol (Paris); 1999 May; 47(5):462-8. PubMed ID: 10418019
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of BAY v 3522, a new oral cephalosporin tested against Haemophilus influenzae and Branhamella catarrhalis.
Doern GV; Tubert TA
Diagn Microbiol Infect Dis; 1990; 13(4):349-52. PubMed ID: 2127558
[TBL] [Abstract][Full Text] [Related]
6. In vitro assessment of the effect of clavulanic acid at concentrations achieved in human serum on the bactericidal activity of amoxicillin at physiological concentrations against Staphylococcus aureus: implications for dosage regimens.
Aguilar L; Martín M; Balcabao IP; Gómez-Lus ML; Dal-Ré R; Prieto J
Antimicrob Agents Chemother; 1997 Jun; 41(6):1403-5. PubMed ID: 9174210
[TBL] [Abstract][Full Text] [Related]
7. Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis.
Davies TA; Kelly LM; Hoellman DB; Ednie LM; Clark CL; Bajaksouzian S; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2000 Mar; 44(3):633-9. PubMed ID: 10681330
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
Blandino G; Aleo G; Caccamo F; Nicolosi VM; Siracusa V; Speciale A
J Chemother; 1996 Jun; 8(3):193-9. PubMed ID: 8808715
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a true post-beta-lactamase-inhibitor effect of clavulanic acid against Klebsiella pneumoniae and Haemophilus influenzae.
Murbach V; Dhoyen N; Linger L; Monteil H; Jehl F
Clin Microbiol Infect; 2001 Dec; 7(12):661-5. PubMed ID: 11843906
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal activity and postantibiotic effect of cefdinir (Cl 983, FK 482) against selected pathogens.
Blandino G; Caccamo F; Di Marco R; Nicoletti A; Speciale A; Nicoletti G
Drugs Exp Clin Res; 1992; 18(8):319-27. PubMed ID: 1292914
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study.
Doern GV; Brueggemann AB; Pierce G; Holley HP; Rauch A
Antimicrob Agents Chemother; 1997 Feb; 41(2):292-7. PubMed ID: 9021182
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Haemophilus influenzae isolates with elevated MICs to amoxicillin/clavulanic acid.
Jacobs MR; Bajaksouzian S
Diagn Microbiol Infect Dis; 1997 Jul; 28(3):105-12. PubMed ID: 9294699
[TBL] [Abstract][Full Text] [Related]
13. Activity of amoxycillin/clavulanic acid (augmentin) against beta-lactamase-positive S. aureus, H. influenzae and B. catarrhalis in an in vitro kinetic model.
Cooper CE; Slocombe B; White AR
J Chemother; 1989 Jul; 1(4 Suppl):350-1. PubMed ID: 16312434
[No Abstract] [Full Text] [Related]
14. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
Bogdanovich T; Clark C; Ednie L; Lin G; Smith K; Shapiro S; Appelbaum PC
Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity and beta-lactamase stability of the new oral cephalosporin Bay v 3522.
Chin NX; Gu JW; Neu HC
Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):685-91. PubMed ID: 2226499
[TBL] [Abstract][Full Text] [Related]
16. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.
Peric M; Browne FA; Jacobs MR; Appelbaum PC
Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118
[TBL] [Abstract][Full Text] [Related]
17. Increased beta-lactamase activity in Branhamella catarrhalis after exposure to amoxicillin and clavulanic acid.
Bedenić B; Zagar Z
J Chemother; 1994 Dec; 6(6):383-7. PubMed ID: 7699424
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
Hsu LY; Chang SC; Luh KT; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of BAY v 3522, a new oral cephalosporin.
Fass RJ
Antimicrob Agents Chemother; 1990 Sep; 34(9):1855-7. PubMed ID: 2126697
[TBL] [Abstract][Full Text] [Related]
20. Comparative bacteriological efficacy of pharmacokinetically enhanced amoxicillin-clavulanate against Streptococcus pneumoniae with elevated amoxicillin MICs and Haemophilus influenzae.
Berry V; Hoover J; Singley C; Woodnutt G
Antimicrob Agents Chemother; 2005 Mar; 49(3):908-15. PubMed ID: 15728883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
